← Human Trials & Peer-Reviewed Studies

Smoking topography in response to denicotinized and high-yield nicotine cigarettes in adolescent smokers.

Plain-language guide to PMID 17185206 (2007): randomized controlled trial of Therapeutic nicotine (patch, non-peptide).

Key Facts

PMID
17185206
Journal
The Journal of adolescent health : official publication of the Society for Adolescent Medicine
Year
2007
Study type
Randomized Controlled Trial
Authors
Kassel JD et al. (7 authors)
DOI
10.1016/j.jadohealth.2006.08.006

What This Study Did, in Plain Language

What Was Tested

This randomized controlled trial looks at Therapeutic nicotine (patch, non-peptide).

The objective of this study was to explore the smoking topography of adolescent smokers.

It is well established that the majority of adult nicotine-dependent smokers began smoking as adolescents.

Whereas recent advances have been made with respect to identification of factors that predispose to nicotine dependence, very little is known about the actual smoking behavior (e.g., topography) of adolescent smokers, or its relationship to nicotine dependence.

Who Took Part

PubMed indexes the participants as teenagers, both men and women.

How the Study Was Run

The design is described as randomized.

Random assignment meant chance, not the researchers, decided who got Therapeutic nicotine (patch, non-peptide) and who got the comparison, which limits bias.

In the present study, the researchers assessed several topographical indices of smoking (e.g., puff volume, puff number) in a sample of 35 light, adolescent smokers.

Moreover, the researchers examined whether smoking behavior is different in response to smoking a denicotinized relative to a high-yield, nicotine cigarette.

What Was Measured

The subject headings attached to it are Adolescent Behavior, Analysis of Variance, Behavior, Addictive, Carbon Monoxide, Chicago, Nicotine and Smoking.

What This Means in Plain Language

The paper is a randomized study of Therapeutic nicotine (patch, non-peptide).

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2007 (The Journal of adolescent health : official publication of the Society for Adolescent Medicine), a journal based in United States.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.

Our Notes on the Compound

Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.